Literature DB >> 22346448

Human herpesvirus 6 and chronic fatigue syndrome.

D Eymard1, F Lebel, M Miller, F Turgeon.   

Abstract

The cause of chronic fatigue syndrome (CFS) is still enigmatic. Using indirect immunofluorescence testing for measuring antibody against human herpesvirus 6 (HHV-6), this study investigated the association of CFS with infection by HHV-6. Seventeen patients (group A) fulfilling the Centers for Disease Control (CDC) definition for CFS were compared with eight patients (group B) with chronic fatigue but not meeting the CDC criteria. No significant difference was found between the two groups for 30 parameters including sex, age, exposure to children and serology for Epstein-Barr virus, cytomegalovirus, herpes simplex virus, and toxoplasma. Univariate analysis showed that patients in group A complained more frequently of a sore throat, headache and of recurrent type of fatigue. These three parameters are discriminant in identifying patients who will meet the CDC case definition of CFS. The titre of antibody against HHV-6 in group A (1:99) was significantly higher than in group B (1:15) (P=0.007). Elevated HHV-6 titres suggests that this virus could be a cofactor in the pathogenesis of CFS.

Entities:  

Keywords:  Chronic fatigue syndrome; Human herpesvirus 6

Year:  1993        PMID: 22346448      PMCID: PMC3250792          DOI: 10.1155/1993/414602

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  19 in total

1.  Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.

Authors:  S E Straus; G Tosato; G Armstrong; T Lawley; O T Preble; W Henle; R Davey; G Pearson; J Epstein; I Brus
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

2.  Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies.

Authors:  J F Jones; C G Ray; L L Minnich; M J Hicks; R Kibler; D O Lucas
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

3.  Chronic fatigue syndrome: clinical condition associated with immune activation.

Authors:  A L Landay; C Jessop; E T Lennette; J A Levy
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

4.  Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers.

Authors:  A Linde; E Fridell; H Dahl; J Andersson; P Biberfeld; B Wahren
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

5.  Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial.

Authors:  S E Straus; J K Dale; M Tobi; T Lawley; O Preble; R M Blaese; C Hallahan; W Henle
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

Review 6.  Human B-lymphotropic virus (human herpesvirus-6).

Authors:  D V Ablashi; S F Josephs; A Buchbinder; K Hellman; S Nakamura; T Llana; P Lusso; M Kaplan; J Dahlberg; S Memon
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

Review 7.  Symptoms and signs of chronic fatigue syndrome.

Authors:  A L Komaroff; D Buchwald
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

8.  Seroprevalence of antibodies against human herpesvirus 6 in the Quebec City area.

Authors:  L Deschênes; J R Joly; M Couillard; G Richer
Journal:  Can J Infect Dis       Date:  1992-07

9.  A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection.

Authors:  Dedra Buchwald; Paul R Cheney; Daniel L Peterson; Berch Henry; Susan B Wormsley; Ann Geiger; Dharam V Ablashi; S Zaki Salahuddin; CArl Saxinger; Royce Biddle; Ron Kikinis; Ferenc A Jolesz; Thomas Folks; N Balachandran; James B Peter; Robert C Gallo; Anthony L Komaroff
Journal:  Ann Intern Med       Date:  1992-01-15       Impact factor: 25.391

10.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

View more
  5 in total

1.  Increased risk of chronic fatigue syndrome following herpes zoster: a population-based study.

Authors:  S-Y Tsai; T-Y Yang; H-J Chen; C-S Chen; W-M Lin; W-C Shen; C-N Kuo; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-09       Impact factor: 3.267

2.  Meta-analysis investigating post-exertional malaise between patients and controls.

Authors:  Abigail Brown; Leonard A Jason
Journal:  J Health Psychol       Date:  2018-07-05

3.  Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection.

Authors:  Sophie A Clarke; Maria Phylactou; Bijal Patel; Edouard G Mills; Beatrice Muzi; Chioma Izzi-Engbeaya; Sirazum Choudhury; Bernard Khoo; Karim Meeran; Alexander N Comninos; Ali Abbara; Tricia Tan; Waljit S Dhillo
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

4.  XMRV and Public Health: The Retroviral Genome Is Not a Suitable Template for Diagnostic PCR, and Its Association with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Appears Unreliable.

Authors:  Simona Panelli; Lorenzo Lorusso; Alessandro Balestrieri; Giuseppe Lupo; Enrica Capelli
Journal:  Front Public Health       Date:  2017-05-22

5.  Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.

Authors:  Liam Townsend; Adam H Dyer; Karen Jones; Jean Dunne; Aoife Mooney; Fiona Gaffney; Laura O'Connor; Deirdre Leavy; Kate O'Brien; Joanne Dowds; Jamie A Sugrue; David Hopkins; Ignacio Martin-Loeches; Cliona Ni Cheallaigh; Parthiban Nadarajan; Anne Marie McLaughlin; Nollaig M Bourke; Colm Bergin; Cliona O'Farrelly; Ciaran Bannan; Niall Conlon
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.